U.S. markets close in 5 hours 8 minutes
  • S&P 500

    3,342.20
    +43.74 (+1.33%)
     
  • Dow 30

    27,603.91
    +429.95 (+1.58%)
     
  • Nasdaq

    11,036.31
    +122.75 (+1.12%)
     
  • Russell 2000

    1,506.35
    +31.44 (+2.13%)
     
  • Crude Oil

    40.40
    +0.15 (+0.37%)
     
  • Gold

    1,872.90
    +6.60 (+0.35%)
     
  • Silver

    23.38
    +0.29 (+1.24%)
     
  • EUR/USD

    1.1655
    +0.0020 (+0.17%)
     
  • 10-Yr Bond

    0.6610
    +0.0020 (+0.30%)
     
  • GBP/USD

    1.2850
    +0.0106 (+0.83%)
     
  • USD/JPY

    105.5920
    +0.0460 (+0.04%)
     
  • BTC-USD

    10,902.47
    +123.66 (+1.15%)
     
  • CMC Crypto 200

    224.62
    +0.70 (+0.31%)
     
  • FTSE 100

    5,952.26
    +109.59 (+1.88%)
     
  • Nikkei 225

    23,511.62
    +307.00 (+1.32%)
     

Isoray to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Isoray, Inc.

RICHLAND, Wash., Sept. 16, 2020 (GLOBE NEWSWIRE) --  Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23 at 1:40 p.m. ET. CEO Woods and Chief Financial Officer Jonathan Hunt will also host virtual one-on-one and group meetings with institutional investors during the conference.

A live webcast of the presentation will be available on Isoray’s Investor Relations section of the Company’s website at https://isoray.com/investors/presentations/. An on-demand replay of the presentation will be available shortly after the conclusion of the presentation on the Investor Relations section of the website and will be available for 90 days.

About Isoray
Isoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter. Join us on Facebook.


CONTACT: Contact: Investor Relations: Mark Levin (501) 255-1910 Media and Public Relations: Sharon Schultz (302) 539-3747